Failure of Responsive Regulation? Pharmaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe

No. Panggil :	eja-21-0361
Nama Orang :	Mulinari, Shai Davis, Courtney Ozieranski, Piotr






Penerbitan :	[Place of publication not identified] : Sage - Crime and Justice, 2021

Entri Tambahan Nama Orang
Abstrak	Responsive regulation has been proposed to offset pharmaceutical industry illicit behavior in areas such as drug marketing based on self-regulation backed up with threats of government sanctions. We explore the efficacy of responsive regulation by tracing recent investigations by the UK pharmaceutical industry self-regulatory authority into the firm Astellas s illicit promotion of a top selling prostate cancer drug. Using documentary data, we reveal a ruthless company culture reflected in the illicit, so-called off label promotion across Europe and the deceptive impression management by company managers during the course of investigations in the UK. We argue for a more probing, adversarial and government-led regulatory approach instead of the self-regulatory approach that shields breaching companies from enforcement actions and associated public scrutiny.
001 Hak Akses (open/membership)	membership
Kata Kunci	pharmaceutical industry, responsive regulation, self-regulation, corporate crime, off-label, marketing
ISSN
Tahun Terbit	2021
No. Induk	eja-21-0361
Entri Sumber Data	Sage - Crime and Justice
Entri Utama Nama orang	Mulinari, Shai; Davis, Courtney; Ozieranski, Piotr
Volume, Nomor, Tahun dan Hlm.	vol. 2, no. 2, p. 69-80
Subjek Topik
Barcode	eja-21-0361
Judul Utama	Failure of Responsive Regulation? Pharmaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe
Kode Bahasa	eng
Sumber Koleksi	Perpustakaan Nasional